Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinical therapeutics

Showing results (1-10 of 7,727) with videos related to

Pageof 773
Sort By:
Clinical Therapeutics|October 9, 2001
Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trialJ J Condemi
Clinical Therapeutics|August 25, 2001
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trialsJ J Caro, M Salas, A Ward
Clinical Therapeutics|July 16, 2002
Statistical comparison of consumer drug expenditures and discretionary purchases to assess drug affordabilityJames A Lee, Patrick L McKercher
Clinical Therapeutics|August 17, 2002
A retrospective assessment of the effectiveness of fenofibrate 267 mg on high-density lipoprotein cholesterol levels in patients attending a lipid clinicCarel W le Roux, Elaine Murphy, Mary Seed
Clinical Therapeutics|June 22, 2002
The prescription drug user fee act: active postmarketing drug surveillance and safetyAlan Lyles
Clinical Therapeutics|October 17, 2002
Compared topical ocular olopatadine 0.1% (Patanol) and loteprednol etabonate 0.2% (Alrex) in an allergen challenge modelGary D Novack
Clinical Therapeutics|October 17, 2002
Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension studyGeorge E Dailey, Pharis Mohideen, Fred T Fiedorek
Clinical Therapeutics|June 11, 1999
Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcersN M Agrawal, J Caldwell, A J Kivitz, et al.
Clinical Therapeutics|June 11, 1999
Meeting the information needs of drug purchasers: the evolution of formulary submission guidelinesP C Langley
Clinical Therapeutics|September 15, 1999
Chlamydia pneumoniae and anti-infective therapy: their role in the pathogenesis and treatment of coronary artery diseaseR Behbahani, C Verme-Gibboney, A M Romanelli
Pageof 773

Showing results (1-10 of 7,727) with videos related to

Sort By:
Pageof 773
Clinical Therapeutics|October 9, 2001
Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trialJ J Condemi
Clinical Therapeutics|August 25, 2001
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trialsJ J Caro, M Salas, A Ward
Clinical Therapeutics|July 16, 2002
Statistical comparison of consumer drug expenditures and discretionary purchases to assess drug affordabilityJames A Lee, Patrick L McKercher
Clinical Therapeutics|August 17, 2002
A retrospective assessment of the effectiveness of fenofibrate 267 mg on high-density lipoprotein cholesterol levels in patients attending a lipid clinicCarel W le Roux, Elaine Murphy, Mary Seed
Clinical Therapeutics|June 22, 2002
The prescription drug user fee act: active postmarketing drug surveillance and safetyAlan Lyles
Clinical Therapeutics|October 17, 2002
Compared topical ocular olopatadine 0.1% (Patanol) and loteprednol etabonate 0.2% (Alrex) in an allergen challenge modelGary D Novack
Clinical Therapeutics|October 17, 2002
Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension studyGeorge E Dailey, Pharis Mohideen, Fred T Fiedorek
Clinical Therapeutics|June 11, 1999
Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcersN M Agrawal, J Caldwell, A J Kivitz, et al.
Clinical Therapeutics|June 11, 1999
Meeting the information needs of drug purchasers: the evolution of formulary submission guidelinesP C Langley
Clinical Therapeutics|September 15, 1999
Chlamydia pneumoniae and anti-infective therapy: their role in the pathogenesis and treatment of coronary artery diseaseR Behbahani, C Verme-Gibboney, A M Romanelli
Pageof 773